retatrutide diabetes trial Phase 2: Type 2 Weight Loss and Key Findings – Bolt Pharmacy Phase-3-Retatrutide-trial-sees-participants-achieve-up-to-30-weight-loss
Description
This article explores the concept of Wegovy microdosing, explains potential reasons for doing so, and discusses whether the practice is safe
Importantly, there were no signals of severe oesophageal complications or cases requiring withdrawal from treatment
launched a biosimilar of the popular anti-diabetic drug Liraglutide in India, marketing it as Lirafit after obtaining approval from the Drug Controller General of India (DCGI)
Heinemann L, Freckmann G, Ehrmann D et al (2018) Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial
One of the most common side effects of these injections is nausea , especially when first starting treatment or increasing dosage
The goal is to achieve even greater weight loss compared to GLP-1 monotherapy
